| 0 |
CONGENITAL HIATUS HERNIA |
2 |
0.0088 |
| 1 |
MALIGNANT MELANOMA STAGE 0 |
1 |
0.0048 |
| 2 |
MALIGNANT MELANOMA IN SITU |
1 |
0.0008 |
| 3 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
1 |
0.0005 |
| 4 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 5 |
BENIGN PROSTATIC HYPERPLASIA |
2 |
0.0004 |
| 6 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 7 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 8 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0003 |
| 9 |
BRONCHIECTASIS |
2 |
0.0003 |
| 10 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 11 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 12 |
MICTURITION URGENCY |
2 |
0.0002 |
| 13 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 14 |
JOINT INJURY |
2 |
0.0001 |
| 15 |
WOUND INFECTION |
1 |
0.0001 |
| 16 |
PEMPHIGUS |
1 |
0.0001 |
| 17 |
HAND DEFORMITY |
1 |
0.0001 |
| 18 |
CORONARY ARTERY DISEASE |
2 |
0.0001 |
| 19 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 20 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 21 |
SYNOVITIS |
1 |
0.0001 |
| 22 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 23 |
WHEEZING |
3 |
0.0001 |
| 24 |
ANGIOEDEMA |
2 |
0.0000 |
| 25 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 26 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 27 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 28 |
DYSPHONIA |
2 |
0.0000 |
| 29 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 30 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 31 |
SWELLING FACE |
2 |
0.0000 |
| 32 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 33 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 34 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 35 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 36 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 37 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 38 |
LEUKOPENIA |
1 |
0.0000 |
| 39 |
OEDEMA |
1 |
0.0000 |
| 40 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 41 |
BLISTER |
1 |
0.0000 |
| 42 |
ASTHMA |
2 |
0.0000 |
| 43 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 44 |
STOMATITIS |
1 |
0.0000 |
| 45 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 46 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 47 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 48 |
HYPERTENSION |
3 |
0.0000 |
| 49 |
TREATMENT FAILURE |
1 |
0.0000 |
| 50 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 51 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 52 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 53 |
JOINT SWELLING |
1 |
0.0000 |
| 54 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 55 |
URTICARIA |
1 |
0.0000 |
| 56 |
OFF LABEL USE |
5 |
0.0000 |
| 57 |
MUSCLE SPASMS |
1 |
0.0000 |
| 58 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 59 |
DYSPNOEA |
2 |
0.0000 |
| 60 |
HEADACHE |
2 |
0.0000 |
| 61 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 62 |
ARTHRALGIA |
1 |
0.0000 |
| 63 |
DIARRHOEA |
1 |
0.0000 |